Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00694980 · ClinicalTrials.gov registry record · Phase 1

A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis

A Phase 1 study of Ulcerative Colitis, sponsored by Genentech.

Completed
Registry status
Phase 1
Development phase
48
Enrollment target
20
Study locations

NCT00694980 is a Phase 1 study of Ulcerative Colitis that has completed, run by Genentech. The registered enrollment target is 48 participants, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00694980, a Phase 1 study of Ulcerative Colitis, has completed, sponsored by Genentech.

COMPLETED
Registry status
Phase 1
Development phase
48 participants
Enrollment target
20
Study locations

Study Summary

This is a randomized , double-blind, placebo-controlled study of approximately 70 patients with ulcerative colitis.

Conditions Studied

Ulcerative Colitis

Interventions

  • DRUG placebo
  • DRUG rhuMAb Beta7

Study Locations (20)

Other

  • - Leuven
  • - Berlin
  • - Frankfurt
  • - Kiel
  • - Regensburg
  • - Ulm

Alberta

  • - Calgary
  • - Edmonton

British Columbia

  • - Vancouver
  • - Victoria

Alabama

  • - Anniston

California

  • - San Francisco

Florida

  • - Gainesville

Georgia

  • - Atlanta

Kentucky

  • - Lexington

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2008-09
Est. Completion 2012-09
Phase Phase 1

Sponsor

Genentech

332 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00694980

The ClinicalTrials.gov registry entry for NCT00694980 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,057-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (98% lower). The listed sponsor is Genentech, which has 332 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 2 interventions - of which placebo is the first listed.

NCT00694980 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Other, Alberta, British Columbia.

Frequently Asked Questions

What is clinical trial NCT00694980 about?

NCT00694980 is a clinical study titled "A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis". This is a randomized , double-blind, placebo-controlled study of approximately 70 patients with ulcerative colitis.

What is the current status of trial NCT00694980?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 48 participants. The study started on 2008-09. Estimated completion is 2012-09.

What conditions does trial NCT00694980 study?

This clinical trial studies the following conditions: Ulcerative Colitis.

What interventions are being tested in trial NCT00694980?

The interventions under investigation include: placebo (DRUG), rhuMAb Beta7 (DRUG).

Who is sponsoring clinical trial NCT00694980?

This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00694980 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Georgia, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ulcerative Colitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ulcerative Colitis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.